127 related articles for article (PubMed ID: 29649795)
1. Effect of Hybrid Blood Purification Treatment on Secondary Hyperparathyroidism for Maintenance Hemodialysis Patients.
Gao XF; Li JD; Guo L; Guo SS; Zhang R; Gou YL; Chen H
Blood Purif; 2018; 46(1):19-26. PubMed ID: 29649795
[TBL] [Abstract][Full Text] [Related]
2. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
Liu J; Liu ZQ; Tao HQ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
[TBL] [Abstract][Full Text] [Related]
3. Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney.
Chen SJ; Jiang GR; Shan JP; Lu W; Huang HD; Ji G; Wu P; Wu GF; Wang W; Zhu C; Bian F
Int J Artif Organs; 2011 Apr; 34(4):339-47. PubMed ID: 21534244
[TBL] [Abstract][Full Text] [Related]
4. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
[TBL] [Abstract][Full Text] [Related]
5. Effect of different hemodialysis modalities on hepcidin clearance in patients undergoing maintenance hemodialysis.
Sun L; Hua RX; Wu Y; Zou LX
Semin Dial; 2023; 36(3):240-246. PubMed ID: 35785435
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and mechanism of hemoperfusion plus hemodialysis for peripheral neuropathy of uremic patients on maintenance hemodialysis].
Cai W; Miao S; Wang P; Xing L
Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1319-22. PubMed ID: 26081662
[TBL] [Abstract][Full Text] [Related]
7. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of optimal hemopurification and parathyroidectomy.
Hida M; Shimbo T; Takeda M; Saito H; Satoh T; Tajima T
Tokai J Exp Clin Med; 1983 Jul; 8(3):229-34. PubMed ID: 6670109
[TBL] [Abstract][Full Text] [Related]
8. Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.
Zheng CM; Wu CC; Hung CF; Liao MT; Shyu JF; Hsu YH; Lu CL; Wang YH; Zheng JQ; Chang TJ; Lin YF; Lu KC
Nutrients; 2018 Feb; 10(2):. PubMed ID: 29439405
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
[TBL] [Abstract][Full Text] [Related]
10. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
11. A Combination of Hemodialysis with Hemoperfusion Helped to Reduce the Cardiovascular-Related Mortality Rate after a 3-Year Follow-Up: A Pilot Study in Vietnam.
Nguyen Huu D; Dao Bui Quy Q; Nguyen Thi Thu H; Phan The C; Nguyen Thi Hong Q; Nguyen Duc L; Do Q; Le Viet T
Blood Purif; 2021; 50(1):65-72. PubMed ID: 32615576
[TBL] [Abstract][Full Text] [Related]
12. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
[TBL] [Abstract][Full Text] [Related]
13. Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients.
Jiang B; Wang X; Yao Z; Wu H; Xiao L; Gong H; Gao Z
Hemodial Int; 2019 Apr; 23(2):247-253. PubMed ID: 30815995
[TBL] [Abstract][Full Text] [Related]
14. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Uremic Tumoral Calcinosis in Maintenance Hemodialysis Patients.
Ke G; Li S; Cui Y; Chen X; Che H; Dou C; Lian Z; Zhang L; Li Z; Ma J; Feng Z; Yang J; Hu Y; Wang Y; Zhang H; Huang H; Su H; Guo J; He C; Liang X; Shi W; Ge P; Liu S
Blood Purif; 2020; 49(6):658-664. PubMed ID: 32289781
[TBL] [Abstract][Full Text] [Related]
16. Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients: Responsiveness is related to parathyroid gland size.
Vulpio C; Maresca G; Distasio E; Cacaci S; Panocchia N; Luciani G; Bossola M
Hemodial Int; 2011 Jan; 15(1):69-78. PubMed ID: 21223484
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of parathyroid hormone after parathyroidectomy in chronic hemodialysis patients.
Skalli Z; Elouazzani H; Alhamany Z; Mattous M; Benamar L; Bayahia R; Belkouchi M; El Malki H; Ouzeddoun N
Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1199-204. PubMed ID: 26586059
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study.
Tonbul HZ; Solak Y; Atalay H; Turkmen K; Altintepe L
Ren Fail; 2012; 34(3):297-303. PubMed ID: 22251408
[TBL] [Abstract][Full Text] [Related]
19. [Effect of calcitriol on secondary hyperparathyroidism].
Xu H; Zhang J; Cheng X; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
[TBL] [Abstract][Full Text] [Related]
20. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
